CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL.
CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL. Blood Adv. 2023 10 24; 7(20):6320-6324.